Dual-phase 68Ga-PSMA-11 PET/CT may increase the rate of detected lesions in prostate cancer patients.

MLA

Dadgar, Habibollah, et al. “Dual-Phase 68Ga-PSMA-11 PET/CT May Increase the Rate of Detected Lesions in Prostate Cancer Patients.” Urologia Journal, vol. 88, no. 4, Nov. 2021, pp. 355–61. EBSCOhost, https://doi.org/10.1177/0391560321993544.

APA

Dadgar, H., Seyedi Vafaee, M., Norouzbeigi, N., Jafari, E., Gholamrezanezhad, A., & Assadi, M. (2021). Dual-phase 68Ga-PSMA-11 PET/CT may increase the rate of detected lesions in prostate cancer patients. Urologia Journal, 88(4), 355–361. https://doi.org/10.1177/0391560321993544

Chicago

Dadgar, Habibollah, Manouchehr Seyedi Vafaee, Nasim Norouzbeigi, Esmail Jafari, Ali Gholamrezanezhad, and Majid Assadi. 2021. “Dual-Phase 68Ga-PSMA-11 PET/CT May Increase the Rate of Detected Lesions in Prostate Cancer Patients.” Urologia Journal 88 (4): 355–61. doi:10.1177/0391560321993544.